- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00844467
A Retrospective Epidemiological Study on Pneumococcal Infection in Children in Ministry of Health Hospital at EHSA Region in the Eastern Province (IPD in saudi)
February 13, 2009 updated by: King Saud University
Serotyping of Pneumococci
The purpose of this study is to establish retrospectively the incidence rates of invasive pneumococcal disease in children aged less than 5 years.
The investigators allocate the El Hasa region for the study because it has higher incidence of sickle cell anemia.
The study will include data from 2003 to 2007(before introduction of the vaccine) and then for 2008 and 2009 (after introduction of the vaccine).
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Data will be collected from patents files or records for 5 years before the introduction of the vaccine and for 2 years after the introduction of the vaccine.
We assigned 4 doctors in each hospital to carry and supervise the work.
Study Type
Observational
Enrollment (Anticipated)
300
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 months to 5 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
children under 5 years with invasive pneumococccal dis.
Description
Inclusion Criteria:
- Invasive pneumococcal disease
- Children under 5 years
- Children lived in Elhasa region
Exclusion Criteria:
- Children above 5 years
- No invasive pneumococcal disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2009
Primary Completion (Anticipated)
October 1, 2009
Study Completion (Anticipated)
December 1, 2009
Study Registration Dates
First Submitted
February 10, 2009
First Submitted That Met QC Criteria
February 13, 2009
First Posted (Estimate)
February 16, 2009
Study Record Updates
Last Update Posted (Estimate)
February 16, 2009
Last Update Submitted That Met QC Criteria
February 13, 2009
Last Verified
February 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- king Saud university (King saud University)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumococcal Infection
-
Merck Sharp & Dohme LLCRecruitingPneumococcal InfectionUnited States
-
London School of Hygiene and Tropical MedicineUniversity College, London; Bill and Melinda Gates Foundation; Wellcome Trust; KEMRI-Wellcome... and other collaboratorsActive, not recruitingPneumococcal Infection | Streptococcus Pneumoniae Infection | Invasive Pneumococcal Disease, Protection AgainstKenya
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionFrance, United States, Canada, Colombia, Finland, Israel, Japan, Spain, Chile, Poland, Sweden, Thailand, Turkey (Türkiye)
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionUnited States, Australia, Belgium, Chile, Germany, Korea, Republic of, New Zealand, Puerto Rico, Sweden, Taiwan, Turkey
-
Merck Sharp & Dohme LLCCompletedPneumococcal Infection
-
LG ChemUnknown
-
Merck Sharp & Dohme LLCCompletedPneumococcal Infection
-
National Institute of Allergy and Infectious Diseases...Completed
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionUnited States, Australia, Canada, Japan, New Zealand, Chile, Poland, South Korea
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionUnited States, Puerto Rico
Clinical Trials on serotypes and resistance
-
SanofiCompletedDengue Fever | Dengue Hemorrhagic FeverPhilippines
-
Serum Institute of India Pvt. Ltd.PPD Australia Pty LtdCompleted
-
Dr. Soetomo General HospitalCompletedCardiorespiratory FitnessIndonesia
-
Universiti Putra MalaysiaCompletedEffect of Instability Resistance Training on Balance, Core Muscle Strength, and Athletic PerformanceAthletic PerformanceMalaysia
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)TerminatedChildhood ObesityUnited States
-
Vienna Hospital AssociationCompleted
-
Princess Nourah Bint Abdulrahman UniversityKırıkkale UniversityCompleted
-
University of KasselCompleted
-
Alexei WongTehran UniversityCompleted